Related Experiment Video

Updated: May 27, 2026

Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter
08:00

Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter

Published on: June 15, 2015

Percutaneous radiofrequency septal reduction for hypertrophic obstructive cardiomyopathy in children

Narayanswami Sreeram1, Mathias Emmel, Joseph V de Giovanni

  • 1Department of Pediatric Cardiology, University Hospital of Cologne, Cologne, Germany.

Journal of the American College of Cardiology
|December 3, 2011
PubMed

Insights

Radiofrequency catheter ablation (RFCA) shows promising results for reducing left ventricular outflow tract obstruction in children with hypertrophic obstructive cardiomyopathy. This minimally invasive approach offers a potential alternative to surgery for these young patients.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Cardiac Electrophysiology

Background:

  • Hypertrophic obstructive cardiomyopathy presents an uncommon yet significant cause of left ventricular outflow tract obstruction in pediatric patients.
  • Historically, surgical myectomy has been the primary intervention for symptomatic children, carrying substantial risks.

Purpose of the Study:

  • To evaluate the effectiveness of radiofrequency catheter ablation (RFCA) as a treatment for hypertrophic obstructive cardiomyopathy in children.
  • To assess RFCA as a less invasive alternative to surgical myectomy.

Main Methods:

  • Radiofrequency catheter ablation (RFCA) was performed on 32 pediatric patients using a cool-tip catheter via a femoral arterial approach.
  • The procedure involved ablating the hypertrophied septum, with a median of 27 lesions applied and a median fluoroscopic time of 24 minutes.

Main Results:

  • A significant reduction in both catheter pullback gradients (mean 78.5 to 36.1 mm Hg) and Doppler echocardiographic gradients (mean 96.9 to 32.7 mm Hg) was observed post-RFCA.
  • One patient experienced mortality due to increased obstruction, and another required permanent pacing for atrioventricular block. Six patients needed additional interventions during follow-up.

Conclusions:

  • Preliminary findings suggest RFCA is a promising therapeutic option for septal reduction in pediatric hypertrophic cardiomyopathy.
  • Further research is warranted to fully establish the long-term efficacy and safety of RFCA in this population.
Abstract

More Related Videos

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...